Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
23
Number of overlapping holdings
10.5%
% of IBBQ's 220 holdings also in FBT
76.7%
% of FBT's 31 holdings also in IBBQ
Overlap by Weight
Sector Drift (IBBQ minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBBQ |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 8.1% | 4.3% | 4.3% |
|
VERTEX PHARMACEUTICALS INC | 8.5% | 4.2% | 4.2% |
|
AMGEN INC | 8.2% | 4.1% | 4.1% |
|
ALNYLAM PHARMACEUTICALS INC | 3.6% | 3.9% | 3.6% |
|
REGENERON PHARMACEUTICALS | 7.1% | 3.2% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
IBBQ Overweight Relative to FBT
 |
ASTRAZENECA PLC-SPONS ADR | 4.4% |
|
VERTEX PHARMACEUTICALS INC | 4.3% |
|
AMGEN INC | 4.2% |
|
REGENERON PHARMACEUTICALS | 3.9% |
|
GILEAD SCIENCES INC | 3.8% |
 |
SANOFI-AVENTIS-ADR | 1.7% |
|
SUMMIT THERAPEUTICS INC | 1.5% |
|
INSMED INC | 1.5% |
|
ROYALTY PHARMA PLC CLASS A | 1.4% |
|
VIATRIS, INC. | 1.1% |
IBBQ Underweight Relative to FBT
|
BEIGENE LTD. SPONSORED ADR | -4.1% |
|
CORCEPT THERAPEUTICS INC | -3.8% |
 |
ALKERMES PLC | -3.5% |
|
HALOZYME THERAPEUTICS INC | -3.4% |
 |
METTLER-TOLEDO INTERNATIONAL | -3.4% |
|
INTRA-CELLULAR THERAPIES INC | -3.4% |
|
WATERS CORP | -3.3% |
|
ACADIA PHARMACEUTICALS INC | -3.1% |
 |
GENMAB A/S SPONSORED ADR | -3.0% |
|
REPLIGEN CORP | -3.0% |